Unilife: Medical Device Innovator Creating Jobs in PA

By Mike Havrilla ProActive Newsroom Unilife Medical Solutions (ASX: UNI.AX) (OTC: UNIFF.PK) is an emerging medical device manufacturer with business segments that include pre-filled syringes for pharmaceutical companies to deliver injectable medications, sharps safety devices for healthcare facilities, and...

Ligand to Buy Struggling Metabasis

Ligand Pharmaceuticals has agreed to buy the struggling Metabasis Therapeutics for $3.2 million in cash.  Metabasis will receive approximately $1.8 million after net liabilities are factored in. The purchase is a positive development for La Jolla, Calif.-based Metabasis, which announced in June that it...

FDA Calendar November Stocks: Turkeys or a Happy Thanksgiving?

By Mike Havrilla ProActive Newsroom On 7/15/09, Cadence Pharma (NASDAQ: CADX) announced that its New Drug Application (NDA) for Acetavance (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and fever in adults and children, has been accepted for filing by the...

OneMedPlace and OneMedForum Enter a Strategic Partnership with MarketWire

OneMedPlace has entered into a partnership with Marketwire, a full-service newswire and communications workflow solutions provider for public relations, investor relations and marketing communications professionals, to accomplish the company’s media outreach goals. As part of this partnership,...

Cohera Receives Approval for Surgical Adhesive Trial

Pittsburgh-based Cohera Medical has received approval to begin clinical trials on its TissuGlu surgical adhesive in Europe. The clinical trials will take place in three cities around Germany: Bonn, Frankfurt and Freiburg. Patient recruitment is expected to start in November. Forty patients will be enrolled...

Interview with Jeffrey Davis, CEO of Access Pharmaceuticals

In August, OneMedPlace reported on MuGard, a preventive treatment for oral mucositis from Access Pharmaceuticals. MuGard is currently being launched in Europe, and is expected to hit the North American market toward the end of 2009. The worldwide market for oral mucositis preventive therapy in patients with...

Zogenix, Astellas Announce Positive Data for Unique Migraine Therapy

Zogenix, a pharmaceutical company specializing in the treatment of chronic pain, and Astellas Pharma have announced positive clinical trial data from two studies of their needle-free migraine treatment system. Sumavel DosePro was approved by the U.S. Food and Drug Administration in July.  It is the first...

Osteologix to Continue Development of Osteoporosis Drug

October 20 is World Osteoporosis Day.  Although the designated day is meant to draw attention to osteoporosis, too many Americans are already aware of the ravages of this destructive bone disease. Osteoporosis is the most common bone disease in humans. The National Osteoporosis Foundation estimates that 10...